Research location
Oakland Park
Florida, United States
Advertisement
Research activity in Oakland Park
Florida, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 65 trials and 65 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Oakland Park
65 linked trials · page 1 of 2Relapse Prevention Trial Evaluating KarXT Treatment in SchizophreniaNCT07686263 · 2026-08-20 · 1 site observation
RECRUITING
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)NCT07202546 · 2026-02-11 · 1 site observation
RECRUITING
HIV-1 Virologic Suppression With TMB-365 and TMB-380 Antibodies StudyNCT07215468 · 2025-12-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With SchizophreniaNCT05848700 · 2023-06-21 · 1 site observation
COMPLETED
Study of Efficacy, Safety, Tolerability and Pharmacokinetics of MIJ821 in Participants With Treatment- Resistant Depression (TRD)NCT05454410 · 2023-03-13 · 1 site observation
COMPLETED
Efficacy, Safety, Tolerability, and Pharmacokinetics of NBI-1117568 in Adults With SchizophreniaNCT05545111 · 2022-10-04 · 1 site observation
COMPLETED
A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With SchizophreniaNCT05443724 · 2022-09-01 · 1 site observation
TERMINATED
A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With SchizophreniaNCT05227690 · 2022-06-30 · 1 site observation
COMPLETED
A Clinical Study That Will Assess How Food Moves Through the Stomach and Effects Blood Glucose Levels in Subjects With Schizophrenia Taking SEP-363856 or and Prior Antipsychotic (PA) StandardNCT05402111 · 2022-06-13 · 1 site observation
COMPLETED
A Study to Test How Well Different Doses of BI 1569912 Are Tolerated and How Well They Work in People With Depression Who Take Anti-depressive MedicationNCT04937829 · 2021-07-20 · 1 site observation
COMPLETED
Study of Efficacy and Safety of MIJ821 in Addition to Comprehensive Standard of Care on the Rapid Reduction of Symptoms of Major Depressive Disorder in Subjects Who Have Suicidal Ideation With IntentNCT04722666 · 2021-07-20 · 1 site observation
TERMINATED
Lumateperone for the Prevention of Relapse in Patients With SchizophreniaNCT04959032 · 2021-07-08 · 1 site observation
COMPLETED
An Open-label Study to Assess the Long-term Safety, Tolerability, and Efficacy of KarXT in Adult Patients With Schizophrenia (EMERGENT-5)NCT04820309 · 2021-06-02 · 1 site observation
COMPLETED
A Clinical Trial Study to Determine the Effect of an Investigational Drug (SEP-363856) Has on the Way That the Drug Metformin Travels Through the Body in People With Schizophrenia.NCT04865835 · 2021-05-12 · 1 site observation
COMPLETED
A Study of SLS-002 (Intranasal Racemic Ketamine) in Adults With Major Depressive Disorder at Imminent Risk of SuicideNCT04669665 · 2020-12-17 · 1 site observation
COMPLETED
A Study to Assess Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Adult Patients With Schizophrenia (EMERGENT-2)NCT04659161 · 2020-12-16 · 1 site observation
COMPLETED
Efficacy and Safety of Elpipodect (MK-8189) in Participants With an Acute Episode of Schizophrenia (MK-8189-008)NCT04624243 · 2020-12-15 · 1 site observation
COMPLETED
A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective DisorderNCT04512066 · 2020-09-08 · 1 site observation
COMPLETED
Safety, Tolerability, and Pharmacokinetics Study of Elpipodect (MK-8189) in Participants With Schizophrenia and Healthy Participants (MK-8189-011)NCT04506905 · 2020-08-28 · 1 site observation
COMPLETED
A Clinical Study to Evaluate the Long-term Safety and Tolerability of an Investigational Drug in People With SchizophreniaNCT04109950 · 2019-11-20 · 1 site observation
TERMINATED
Integrase Regimen Switch to Symtuza to Increase Tolerability/Adherence (SYMita)NCT04240210 · 2019-09-17 · 1 site observation
TERMINATED
Rapid Test and Treat Dolutegravir Plus Lamivudine Study in Newly Diagnosed Human Immunodeficiency Virus (HIV)-1 Infected AdultsNCT03945981 · 2019-07-02 · 1 site observation
COMPLETED
Study of Adjunctive or Monotherapy Rapastinel Treatment in Patients With Major Depressive Disorder (MDD)NCT03668600 · 2018-08-23 · 1 site observation
TERMINATED
Efficacy, Safety & Tolerability of Switching EFV/TDF/FTC to BIC/FTC/TAF in Virologically Suppressed Adults With HIV-1NCT03502005 · 2018-03-01 · 1 site observation
COMPLETED
A Study of Rapastinel for Rapid Treatment of Depression and Suicidality in Major Depressive DisorderNCT03352453 · 2017-12-15 · 1 site observation
TERMINATED
Study to Evaluate Efficacy and Safety of Roluperidone (MIN-101) in Adult Patients With Negative Symptoms of SchizophreniaNCT03397134 · 2017-12-15 · 1 site observation
COMPLETED
An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)NCT03055338 · 2017-03-08 · 1 site observation
COMPLETED
Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive DisorderNCT03002077 · 2017-02-03 · 1 site observation
COMPLETED
A Study of Rapastinel as Adjunctive Therapy in the Prevention of Relapse in Patients With Major Depressive DisorderNCT02951988 · 2016-11-13 · 1 site observation
COMPLETED
Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With SchizophreniaNCT02892422 · 2016-08-01 · 1 site observation
COMPLETED
Effect of Lu AF35700 in Patients With Treatment-resistant SchizophreniaNCT02717195 · 2016-04-01 · 1 site observation
COMPLETED
A Study of ALKS 3831 in Adults With Schizophrenia (The ENLIGHTEN-2 Study)NCT02694328 · 2016-03-02 · 1 site observation
COMPLETED
Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeNCT02446132 · 2015-11-13 · 1 site observation
TERMINATED
Study to Evaluate the Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Alafenamide in Human Immunodeficiency Virus (HIV-1) Infected, Antiretroviral Treatment-Naive AdultsNCT02607956 · 2015-11-11 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeNCT02442765 · 2015-07-23 · 1 site observation
COMPLETED
An Open-Label Study of Aripiprazole Lauroxil in Subjects With Stable SchizophreniaNCT02320032 · 2014-12-01 · 1 site observation
COMPLETED
A Study of ALKS 5461 for the Treatment of Major Depressive Disorder (MDD) - FORWARD-5 StudyNCT02218008 · 2014-07-01 · 1 site observation
COMPLETED
A Long-Term Safety Study of ALKS 5461NCT02141399 · 2014-05-01 · 1 site observation
COMPLETED
A Study of ALKS 3831 in Subjects With Schizophrenia and Alcohol Use DisorderNCT02161718 · 2014-05-01 · 1 site observation
COMPLETED
OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult FemalesNCT02116361 · 2014-04-22 · 1 site observation
COMPLETED
Safety and Efficacy of Vilazodone in Adolescent Patients With Major Depressive DisorderNCT01878292 · 2013-07-11 · 1 site observation
COMPLETED
A Study of ALKS 3831 in Adults With SchizophreniaNCT01903837 · 2013-06-01 · 1 site observation
COMPLETED
A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic TherapyNCT01714713 · 2013-06-01 · 1 site observation
COMPLETED
Long-term Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy in Patients With Major Depressive DisorderNCT01838876 · 2013-04-29 · 1 site observation
COMPLETED
A 36-Week Safety Extension Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseNCT01766336 · 2013-01-01 · 1 site observation
TERMINATED
A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus TrialNCT01727726 · 2012-12-01 · 1 site observation
COMPLETED
Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD)NCT01715805 · 2012-11-15 · 1 site observation
COMPLETED
Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's DiseaseNCT01735630 · 2012-11-01 · 1 site observation
COMPLETED
Study of the Efficacy and Safety of LY2940094 in Participants With Major Depressive Disorder (MDD)NCT01724112 · 2012-11-01 · 1 site observation
COMPLETED
A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin TherapyNCT01649297 · 2012-10-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.